Detail (Long)
Strong antibody response in children 5-11 yo, similar to young adults, per phase 2/3 study (<a href=https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-top-line-data-phase-23-study-covid-19><b><u>press release</u></b></a>)